Ikarian Capital »

Biohaven shares owned by Ikarian Capital

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 224k 54.69
2023-09-30 $2.8M 106k 26.01
2023-06-30 $16M 652k 23.92
2023-03-31 $6.1M 448k 13.66
2022-12-31 $12M 838k 13.88

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Biohaven

Vanguard Group
Stifel Financial
BlackRock
Henderson Group
Suvretta Capital Management
State Street Corporation
T. Rowe Price Associates
RP Management
Farallon Capital Management
Bellevue Group
Citadel Advisors
Holocene Advisors
Geode Capital Management
Perceptive Advisors
Armistice Capital

View all funds holding Biohaven